Bicocca Open Archive

Logo unimib boa
FAZIO, FERRUCCIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 46.273
AS - Asia 20.362
EU - Europa 17.363
SA - Sud America 2.744
Continente sconosciuto - Info sul continente non disponibili 414
AF - Africa 369
OC - Oceania 29
Totale 87.554
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 43.660
SG - Singapore 7.298
CN - Cina 5.029
HK - Hong Kong 3.134
IT - Italia 2.953
SE - Svezia 2.690
RU - Federazione Russa 2.631
CA - Canada 2.361
UA - Ucraina 2.309
BR - Brasile 2.114
IE - Irlanda 2.037
VN - Vietnam 2.010
DE - Germania 1.828
GB - Regno Unito 945
FR - Francia 716
BD - Bangladesh 611
FI - Finlandia 586
IN - India 464
KR - Corea 385
AR - Argentina 258
TR - Turchia 219
NL - Olanda 206
IQ - Iraq 192
JP - Giappone 143
ZA - Sudafrica 131
PK - Pakistan 127
MX - Messico 116
EC - Ecuador 107
SA - Arabia Saudita 101
ID - Indonesia 95
PH - Filippine 85
PL - Polonia 85
CO - Colombia 72
UZ - Uzbekistan 68
ES - Italia 61
VE - Venezuela 59
MY - Malesia 51
MA - Marocco 50
BE - Belgio 49
AT - Austria 43
CL - Cile 41
TH - Thailandia 40
KE - Kenya 37
IR - Iran 35
AE - Emirati Arabi Uniti 33
PY - Paraguay 33
NP - Nepal 30
JM - Giamaica 28
KZ - Kazakistan 28
ET - Etiopia 27
IL - Israele 27
PE - Perù 27
EU - Europa 26
TN - Tunisia 26
CR - Costa Rica 25
CH - Svizzera 23
DK - Danimarca 23
EG - Egitto 23
OM - Oman 22
RO - Romania 21
UY - Uruguay 20
DZ - Algeria 19
GR - Grecia 19
JO - Giordania 18
AZ - Azerbaigian 17
LT - Lituania 17
PT - Portogallo 17
PS - Palestinian Territory 16
AU - Australia 15
CZ - Repubblica Ceca 14
BG - Bulgaria 13
BO - Bolivia 12
DO - Repubblica Dominicana 12
HN - Honduras 12
TT - Trinidad e Tobago 12
AL - Albania 11
KW - Kuwait 11
LB - Libano 11
NI - Nicaragua 11
NZ - Nuova Zelanda 11
BH - Bahrain 9
KG - Kirghizistan 9
NG - Nigeria 9
BA - Bosnia-Erzegovina 8
GT - Guatemala 8
HU - Ungheria 8
PA - Panama 7
RS - Serbia 7
AO - Angola 6
BY - Bielorussia 6
GE - Georgia 6
LY - Libia 6
MK - Macedonia 6
TW - Taiwan 6
A2 - ???statistics.table.value.countryCode.A2??? 5
NO - Norvegia 5
SK - Slovacchia (Repubblica Slovacca) 5
BB - Barbados 4
EE - Estonia 4
LV - Lettonia 4
Totale 87.070
Salva come PNG Salva come JPEG
Città #
Ann Arbor 4.865
Woodbridge 4.590
Singapore 3.918
Ashburn 3.734
Houston 3.471
Hong Kong 3.093
Fairfield 2.971
Jacksonville 2.567
Chandler 1.982
Dublin 1.920
Toronto 1.672
Dearborn 1.430
San Jose 1.325
Wilmington 1.176
Seattle 1.081
New York 1.044
Cambridge 975
Santa Clara 911
Milan 872
Princeton 848
Frankfurt am Main 824
Hefei 732
Chicago 662
The Dalles 652
Beijing 624
Council Bluffs 602
Ho Chi Minh City 563
Dallas 520
Nanjing 458
Hanoi 448
Lawrence 423
Lachine 421
Altamura 413
Los Angeles 403
Lauterbourg 371
Seoul 366
Shanghai 313
Moscow 285
Rome 236
Buffalo 211
San Diego 206
São Paulo 192
Shenyang 179
Boardman 159
Changsha 152
Nanchang 142
Huizen 136
Andover 135
Helsinki 135
Guangzhou 130
Munich 128
Hebei 120
Tianjin 111
Jiaxing 104
London 104
Dong Ket 100
Falls Church 97
Mountain View 93
Ottawa 93
Tokyo 84
Baghdad 79
Da Nang 77
Haiphong 77
Jinan 73
Salt Lake City 73
Zhengzhou 73
Philadelphia 66
Rio de Janeiro 60
Turin 59
Columbus 58
Brooklyn 57
Tashkent 57
Phoenix 56
Orem 55
Dhaka 54
University Park 52
Norwalk 50
Warsaw 50
Ningbo 48
Johannesburg 47
Hangzhou 46
Tampa 45
Brussels 44
Chennai 44
Figino 44
Montreal 44
Jeddah 43
Nürnberg 42
Atlanta 41
Lahore 41
Naples 41
Elk Grove Village 40
Auburn Hills 39
Detroit 39
Belo Horizonte 37
Denver 37
Curitiba 36
Montréal 36
Quito 36
San Francisco 36
Totale 58.604
Salva come PNG Salva come JPEG
Nome #
Synthesis, labeling, and biological evaluation of halogenated 2-quinolinecarboxamides as potential radioligands for the visualization of peripheral benzodiazepine receptors 535
Economic analyses on the use of positron emission tomography for the work-up of solitary pulmonary nodules and for staging patients with non-small-cell-lung-cancer in Italy 501
11C-Labelling of N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide Derivatives and Evaluation as Potential Radioligands for PET imaging of Dopamine D3 Receptors 471
Evaluation of three quinoline-carboxamide derivatives as potential radioligands for the in vivo pet imaging of neurodegeneration 460
Cholinergic ligand [C-11]MP4A: Improved 4-acetoxypiperidine precursor synthesis via LC-APCI/MS characterisation and improved radioligand HPLC purification 457
In vivo imaging of adenosine A2A receptors in rat and primate brain using [11C]SCH442416 456
11C-radiosynthesis and preliminary human evaluation of the disposition of the ACE inhibitor [11C]Zofenoprilat 414
FDG/PET and spiral CT image fusion for medistinal lymph node assessment of non-small cell lung cancer patients 396
Improved synthesis and radiolabeling of [C-11]MP4A, a suitable ligand for the investigation of the cholinergic system using PET 373
Functional heterogeneity of left inferior frontal cortex as revealed by fMRI 362
Characterization of biological features of a rat F98 GBM model: a PET-MRI study with [18F]FAZA and [18F]FDG 358
Time course of metabolic activity and cellular infiltration in a murine model of acid-induced lung injury 353
Perfusion CT in cirrhotic patients with early stage hepatocellular carcinoma: Assessment of tumor-related vascularization 347
Changes in glucose metabolism during and after radiotherapy in non-small cell lung cancer 337
Synthesis and in vivo evaluation of 3-[C-11]methyl-(3-methoxy-naphthalen)-2-yl-(1-benzyl-piperidin)-4-yl-acetate (SB-235753), as a putative dopamine D-4 receptors antagonist for PET 330
11C-Choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy 325
Choline and phosphatidylcholine fluorescent derivatives localization in carcinoma cells studied by laser scanning confocal fluorescence microscopy 324
Monitoring disease evolution and treatment response in lysosomal disorders by the peripheral benzodiazepine receptor ligand PK11195 322
Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety 322
Multi-modal medical image integration to optimize radiotherapy planning in lung cancer treatment 321
Evaluation of the role of tumor-associated macrophages in an experimental model of peritoneal carcinomatosis using 18F-FDG PET 321
Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation 321
Hepatocellular carcinoma treated with transarterial chemoembolization: Dynamic perfusion-CT in the assessment of residual tumor 320
Performance evaluation of the new whole-body PET/CT scanner: Discovery ST 318
Lungs of patients with acute respiratory distress syndrome show diffuse inflammation in normally aerated regions: A [18F]-fluoro-2-deoxy-D-glucose PET/CT study 317
C-11 choline versus F-18 fluorodeoxyglucose for imaging meningiomas: An initial experience 317
[11C]RN5: A new agent for the in vivo imaging of myocardial α1-adrenoceptors 315
Characterization of preclinical models of prostate cancer using PET-based molecular imaging 314
4D-PET data sorting into different number of phases: a NEMA IQ phantom study 313
Automated production of copper radioisotopes and preparation of high specific activity [(64)Cu]Cu-ATSM for PET studies 312
Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization 311
The p53-p66Shc apoptotic pathway is dispensable for tumor suppression whereas the p66Shc-generated oxidative stress initiates tumorigenesis 310
Perfusion computed tomographic assessment of early hepatocellular carcinoma in cirrhotic liver disease: initial observations 302
Left caloric vestibular stimulation ameliorates right hemianesthesia 301
Patients with known or suspected lung cancer: evaluation of clinical management changes due to f-fluorodeoxyglucose positron emission tomography (f-fdg pet) study 300
Fluoro-deoxi-glucose uptake and angiogenesis are independent biological features in lung metastases 300
Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer 298
Acupuncture produces central activations in pain regions 290
Lesion detectability and quantification in PET/CT oncological studies by Monte Carlo simulations 289
Apomorphine-induced brain modulation during sexual stimulation: A new look at central phenomena related to erectile dysfunction 288
Basal ganglia and language: Phonology modulates dopaminergic release 287
Synthesis and in vivo evaluation of [11C]ICI 118551 as a putative subtype selective β2-adrenergic radioligand 283
Localization of grasp representations in humans by PET: 1. Observation versus execution 283
A publicly accessible Monte Carlo database for validation purposes in emission tomography 277
Synthesis and carbon-11 labeling of (R)- and (S)-Thionisoxetine, norepinephrine reuptake inhibitors, potential radioligands for Positron Emission Tomography 277
Pre-transplant 18FDG-PET predicts outcome in lymphoma patients treated with high-dose sequential chemotherapy followed by autologous stem cell transplantation 275
Data rebinning and reconstruction in 3D PET/CT oncological studies: a Monte Carlo evaluation. 273
Positron emission tomography/computed tomography introduction in the clinical management of patients with suspected recurrence of ovarian cancer: A cost-effectiveness analysis 273
Development of a bicistronic vector for multimodality imaging of estrogen receptor activity in a breast cancer model: preliminary application 271
Positron emission tomography in neuronal ceroid lipofuscinosis (Jansky-Bielschowsky disease): a case report 270
A modified damped Richardson-Lucy algorithm to reduce isotropic background effects in spherical deconvolution 270
PET and SPET molecular imaging: Focus on serotonin system 267
Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy 267
Asymmetric synthesis and preliminary evaluation of (R)- and (S)-[11C]bisoprolol, a putative beta1-selective adrenoceptor radioligand 266
SPET imaging of cerebral perfusion in patients with non‐refractory temporal lobe epilepsy 265
A voxel-based PET study of dopamine transporters in Parkinson's disease: relevance of age at onset 264
Progressive dysphasic dementia with bucco-facial apraxia: A case report 264
Supercalifragilisticexpialidocious: How the brain learns words never heard before 264
Assessment of myocardial perfusion and viability with technetium-99m methoxyisobutylisonitrile and thallium-201 rest redistribution in chronic coronary artery disease 263
A Monte Carlo model of noise components in 3-D PET 263
The role of age of acquisition and language usage in early, high-proficient bilinguals: an fMRI study during verbal fluency 262
Myocardial insulin resistance associated with chronic hypertriglyceridemia and increased FFA levels in Type 2 diabetic patients 261
Radiosynthesis of [123I]βCIT, a selective ligand for the study of the dopaminergic and serotoninergic systems in human brain 261
High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients 260
Syntax and the brain: Disentangling grammar by selective anomalies 259
Evaluation of pre- and post-reconstruction count-dependent Metz filters for brain PET studies 259
Nonpalpable breast lesions: preoperative radiological guidance in radioguided occult lesion localisation (ROLL). Lesioni mammarie non palpabili: la guida radiologica preoperatoria nella ROLL (radioguided occult lesion localisation) 258
Labeling and evaluation of N-[11C]methylated quinoline-2-carboxamides as potential radioligands for visualization of peripheral benzodiazepine receptors 256
Evaluation of [O-methyl-(11)C]fluvoxamine as a tracer for serotonin re-uptake sites 256
Cost-effectiveness analysis in the clinical management of patients with known or suspected lung cancer: [(18F)]fluorodeoxyglucose PET and CT comparison 255
Positron emission tomograhy for the assessment of myocardial viability: A sinopsys of methods and indications 255
Whole-body scintigraphy with 99Tcm-mibi, 18f-fdg and 131I in patients with metastatic thyroid carcinoma 255
Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer 254
Isolated amnesia with slow onset and stable course, without ensuing dementia: MRI and PET data and a six-year neuropsychological follow-up 254
Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence 253
Pathways of interhemispheric transfer in normals and in a split-brain subject. A positron emission tomography study 251
Increased C-11 choline uptake in pagetic bone in a patient with coexisting skeletal metastases from prostate cancer 250
Metabolic impairment in human amnesia: a PET study of memory networks 250
Mri, antibody-guided scintigraphy, and glucose metabolism in uveal melanoma 249
Acute effect of 3-(4-acetamido)-butyrril-lorazepam (dds2700) on brain function assessed by pet at rest and during attentive tasks 249
Systemic and cerebral kinetics of 16α[18F]fluoro-17β-estradiol: A ligand for the in vivo assessment of estrogen receptor binding parameters 249
GABAa receptor abnormalities in Prader-Willi syndrome assessed with positron emission tomography and [11C]flumazenil 248
Integrated CT/PET systems 248
Myocardial glucose uptake evaluated by positron emission tomography and fluorodeoxyglucose during hyperglycemic clamp in IDDM patients: Role of free fatty acid and insulin levels 248
[(11)C]Choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy 247
In vivo serotonin 5HT(2A) receptor binding and personality traits in healthy subjects: a positron emission tomography study 247
Measurement and control of the air contamination generated in a medical cyclotron facility for PET radiopharmaceuticals 247
An automatic classification technique for attenuation correction in positron emission tomography 247
Synthesis and Biodistribution of (R,S)-[O-Methyl-11C]-1-[3-(5-Methoxy-1,2,3,4-Tetrahydro-1-Naphtalenyl)Propyl]-4-Phenylpiperazine (PNU-157760), A Putative Radioligand for 5-HT1A Receptors 247
In vivo PET study of 5HT2A serotonin and D2 dopamine dysfunction in drug-naive obsessive-compulsive disorder 246
Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method 246
Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease 246
Head holder for PET, CT, and MR studies 246
Sensitive GC-MS method for the determination of specific-activity of 16a[18F]Fluoro-estra-1,3,5(10)-triene-3,17b-diol 245
Determination of extravascular lung water by dilution methods. I. Theoretical considerations 245
Relation between dobutamine trans-thoracic echocardiography, 99Tcm-MIBI and 18FDG uptake in chronic coronary artery disease 244
Preserved functional competence of perilesional areas in drug-resistant epilepsy with lesion in supplementary motor cortex: fMRI and neuropsychological observations. 244
Remodelling of sensorimotor maps in paraplegia: a functional magnetic resonance imaging study after a surgical nerve transfer 243
Synthesis and Biological Characterization of Novel 2-Quinolinecarboxamide Ligands of the Peripheral Benzodiazepine Receptors Bearing Technetium-99m or Rhenium 243
Different brain correlates for watching real and virtual hand actions 243
Totale 29.369
Salva come PNG Salva come JPEG
Categoria #
all - tutte 292.091
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 292.091
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.566 0 478 767 563 272 238 218 263 263 271 414 819
2022/20237.521 1.043 2.344 421 658 580 1.234 98 330 499 34 207 73
2023/20244.881 163 159 171 145 780 1.374 1.055 122 464 21 46 381
2024/202510.645 717 1.586 405 456 951 270 340 499 1.200 1.360 917 1.944
2025/202626.650 2.073 1.952 2.089 2.601 2.520 1.530 3.377 1.592 2.274 1.985 2.444 2.213
2026/20271.615 824 791 0 0 0 0 0 0 0 0 0 0
Totale 87.554